Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04875416 · ClinicalTrials.gov registry record

Phenotype, Genotype and Biomarkers 2

A clinical trial of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia, sponsored by University of Miami.

Active
Registry status
217
Enrollment target
4
Study locations

NCT04875416 is a study of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 217 participants, below the 896-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (76% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04875416, a study of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia, is active but no longer recruiting, sponsored by University of Miami.

ACTIVE NOT RECRUITING
Registry status
217 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to learn more about amyotrophic lateral sclerosis (ALS) and other related neurodegenerative diseases, including frontotemporal dementia (FTD), primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), progressive muscular atrophy (PMA) and multisystem proteinopathy (MSP). More precisely, the investigator wants to identify the links that exist between the disease phenotype (phenotype refers to observable signs and symptoms) and the disease genotype (genotype refers to your genetic information). The investigator also wants to identify biomarkers of ALS and related diseases.

Conditions Studied

Amyotrophic Lateral Sclerosis Frontotemporal Dementia Primary Lateral Sclerosis Hereditary Spastic Paraplegia Progressive Muscular Atrophy

Study Locations (4)

Florida

  • University of Miami - Miami

Kansas

  • University of Kansas Medical Center - Kansas City

Pennsylvania

  • University of Pennsylvania - Philadelphia

Other

  • University of Cape Town - Cape Town

Trial Details

FieldValue
Enrollment Target 217 participants
Start Date 2021-01-08
Est. Completion 2028-08

Sponsor

University of Miami

721 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04875416

The ClinicalTrials.gov registry entry for NCT04875416 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 217 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 896-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (76% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT04875416 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Florida, Kansas, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04875416 about?

NCT04875416 is a clinical study titled "Phenotype, Genotype and Biomarkers 2". The purpose of this study is to learn more about amyotrophic lateral sclerosis (ALS) and other related neurodegenerative diseases, including frontotemporal dementia (FTD), primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), progressive muscular atrophy (PMA) and multisystem protein...

What is the current status of trial NCT04875416?

This trial is currently active not recruiting. The enrollment target is 217 participants. The study started on 2021-01-08. Estimated completion is 2028-08.

What conditions does trial NCT04875416 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Primary Lateral Sclerosis, Hereditary Spastic Paraplegia, Progressive Muscular Atrophy.

Who is sponsoring clinical trial NCT04875416?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04875416 being conducted?

This trial has 4 study locations across Florida, Kansas, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Amyotrophic Lateral Sclerosis

All registered trials for this condition

Frontotemporal Dementia

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.